Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasacort AQ growth velocity study in children with perennial allergic rhinitis
2014-004645-27Phase 4
- Sponsor
- Sanofi
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in perennial rhinitis comparing Triamcinolone acetonide nasal spray with Placebo nasal spray (2 arms). Primary endpoint: Growth velocity.
02
Drugs
triamcinolone acetonide
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on 2014-004645-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004645-27.